Compare NEOG & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | WLFC |
|---|---|---|
| Founded | 1981 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 1995 | 1997 |
| Metric | NEOG | WLFC |
|---|---|---|
| Price | $9.62 | $222.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $10.67 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 1.8M | 144.0K |
| Earning Date | 04-09-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | N/A | ★ 146.23 |
| EPS | 0.02 | ★ 3.26 |
| Revenue | ★ $894,661,000.00 | $569,223,000.00 |
| Revenue This Year | N/A | $2.75 |
| Revenue Next Year | N/A | $7.35 |
| P/E Ratio | $487.50 | ★ $69.12 |
| Revenue Growth | N/A | ★ 36.00 |
| 52 Week Low | $4.56 | $114.01 |
| 52 Week High | $11.43 | $244.62 |
| Indicator | NEOG | WLFC |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 58.66 |
| Support Level | $8.43 | $165.65 |
| Resistance Level | $10.30 | $239.44 |
| Average True Range (ATR) | 0.42 | 11.85 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 85.09 | 55.33 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.